Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02669836 · ClinicalTrials.gov registry record · NA
Posterior Fossa Decompression With or Without Duraplasty for Chiari Type I Malformation With Syringomyelia
A NA study of Syringomyelia and Arnold-Chiari Malformation, Type 1, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 162
- Enrollment target
- 1
- Study location
NCT02669836 is a NA study of Syringomyelia and Arnold-Chiari Malformation, Type 1 that has completed, run by Washington University School of Medicine. The registered enrollment target is 162 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02669836, a NA study of Syringomyelia and Arnold-Chiari Malformation, Type 1, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 162 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether a posterior fossa decompression or a posterior fossa decompression with duraplasty results in better patient outcomes with fewer complications and improved quality of life in those who have Chiari malformation type I and syringomyelia.
Conditions Studied
Interventions
- PROCEDURE Posterior fossa decompression
- PROCEDURE Dural Augmentation
Study Locations (1)
Missouri
- St. Louis Children's Hospital - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 162 participants |
| Start Date | 2016-04 |
| Est. Completion | 2020-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02669836
The ClinicalTrials.gov registry entry for NCT02669836 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 162 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Syringomyelia appearing as the primary indexed condition, and to 2 interventions - of which Posterior fossa decompression is the first listed.
NCT02669836 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT02669836 about?
NCT02669836 is a clinical study titled "Posterior Fossa Decompression With or Without Duraplasty for Chiari Type I Malformation With Syringomyelia". The purpose of this study is to determine whether a posterior fossa decompression or a posterior fossa decompression with duraplasty results in better patient outcomes with fewer complications and improved quality of life in those who have Chiari malformation type I and syringomyelia.
What is the current status of trial NCT02669836?
This trial is currently completed. It is a NA study. The enrollment target is 162 participants. The study started on 2016-04. Estimated completion is 2020-07-31.
What conditions does trial NCT02669836 study?
This clinical trial studies the following conditions: Syringomyelia, Arnold-Chiari Malformation, Type 1, Chiari Malformation Type I, Type I Arnold-Chiari Malformation.
What interventions are being tested in trial NCT02669836?
The interventions under investigation include: Posterior fossa decompression (PROCEDURE), Dural Augmentation (PROCEDURE).
Who is sponsoring clinical trial NCT02669836?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02669836 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Syringomyelia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.